日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Emerging Horizons in Laser-Based Additive Manufacturing of Titanium Alloys and Composites for Biomedical Applications: A Comprehensive Review

激光增材制造钛合金及复合材料在生物医学应用领域的新兴前景:一项综合综述

Tahriri, Mohammadreza; Ghorbani Moghaddam, Masoud; Alavi, S Habib; Moghanian, Amirhossein; Razeghi, Mir Hadi; Azie, Obiora; Berzins, David; Tayebi, Lobat

P-103. Adenoviremia Clearance Following Treatment with Intravenous (IV) Brincidofovir (BCV) in Immunocompromised Patients is Associated with Positive Clinical Disease Response: Preliminary Outcomes from the ATHENA Phase IIa Study

P-103. 免疫功能低下患者接受静脉注射布林西多福韦 (BCV) 治疗后腺病毒血症清除与积极的临床疾病反应相关:ATHENA IIa 期研究的初步结果

LEVI, L; WALKER, G C; PUGSLEY, L I; Maron, Gabriela; Boeckh, Michael J; Papanicolaou, Genovefa; Gomez, Carlos; Prasad, Vinod; Dara, Jasmeen; Elgarten, Caitlin; Kumar, Madan; Wynn, Robert; Lion, Thomas; Fukushima, Koji; Maher, Rochelle; Azie, Nkechi; Grimley, Michael

New insights into the diversity of cryptobenthic Cirripectes blennies in the Mascarene Archipelago sampled using Autonomous Reef Monitoring Structures (ARMS)

利用自主礁体监测结构(ARMS)对马斯克林群岛隐底栖鱼类 Cirripectes 鳚的多样性进行了新的研究

Couëdel, Marion; Dettai, Agnes; Guillaume, Mireille M M; Bruggemann, Fleur; Bureau, Sophie; Frattini, Baptiste; Verde Ferreira, Amélie; Azie, Jean-Lindsay; Bruggemann, J Henrich

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)

伊布沙芬普与安慰剂治疗外阴阴道念珠菌病:一项 3 期随机对照优效性试验 (VANISH 303)

Schwebke, Jane R; Sobel, Ryan; Gersten, Janet K; Sussman, Steven A; Lederman, Samuel N; Jacobs, Mark A; Chappell, B Todd; Weinstein, David L; Moffett, Alfred H; Azie, Nkechi E; Angulo, David A; Harriott, Itzel A; Borroto-Esoda, Katyna; Ghannoum, Mahmoud A; Nyirjesy, Paul; Sobel, Jack D

Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis

口服伊布沙芬普与氟康唑治疗外阴阴道念珠菌病的II期随机研究

Nyirjesy, Paul; Schwebke, Jane R; Angulo, David A; Harriott, Itzel A; Azie, Nkechi E; Sobel, Jack D

P056 Oral Ibrexafungerp outcomes by fungal disease in patients from an interim analysis of a Phase 3 Open-label Study (FURI)

P056 口服 Ibrexafungerp 治疗真菌病患者的疗效(来自一项 3 期开放标签研究 (FURI) 的中期分析)

Espinel-Ingroff, A; Canton, E; Fothergill, A; Ghannoum, M; Johnson, E; Jones, R N; Ostrosky-Zeichner, L; Schell, W; Gibbs, D L; Wang, A; Turnidge, J; Kermani, Firoozeh; Taghizadeh‐Armaki, Mojtaba; Hosseini, Seyed Abdollah; Amirrajab, Nasrin; Javidnia, Javad; Zaghrami, Mahmoud Fami; Shokohi, Tahereh; Nasri, Elahe; Fakhim, Hamed; Vaezi, Afsane; Mirhendi, Hossein; Rizi, Mahnaz Hosseini; Shelerangkon, Mahsa; Ghafel, Safiyeh; Badali, Hamid; Ghazanfari, Sahar; mohammadi, Shahla Roudbar; Rezaei, Sasan; Prattes, Juergen; King, Thomas; Azie, Nkechi; Angulo, David

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo-controlled superiority study (VANISH 306)

口服伊布沙芬普治疗急性外阴阴道念珠菌病的疗效和安全性:一项全球 3 期随机安慰剂对照优效性研究 (VANISH 306)

Sobel, R; Nyirjesy, P; Ghannoum, M A; Delchev, D A; Azie, N E; Angulo, D; Harriott, I A; Borroto-Esoda, K; Sobel, J D

Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections

Ibrexafungerp,一种正在研发中的新型三萜类抗真菌药物,用于治疗霉菌感染

Angulo, David A; Alexander, Barbara; Rautemaa-Richardson, Riina; Alastruey-Izquierdo, Ana; Hoenigl, Martin; Ibrahim, Ashraf S; Ghannoum, Mahmoud A; King, Thomas R; Azie, Nkechi E; Walsh, Thomas J

473. Diabetes Mellitus as a Risk Factor for Cryptococcosis — a Multicenter Research Network Study

473. 糖尿病作为隐球菌病的危险因素——一项多中心研究网络研究

Rajasingham, Radha; Nalintya, Elizabeth; Israelski, Dennis M; Meya, David B; Larson, Bruce A; Boulware, David R; Pek, Zachary; Bork, Jacqueline T; Baddley, John W; Chowdhary, Anuradha; Wurster, Sebastian; Gupta, Nitesh; Mohabir, Jason; Tatavarthy, Shashidhar; Mittal, Vikas; Sharma, Brijesh; Jiang, Ying; Cuomo, Christina; Kontoyiannis, Dimiitrios P; Shah, Meera D; Christina Gutierrez, G; Moote, Rebecca; Reveles, Kelly R; Hand, Elizabeth O; Hoenigl, Martin; Egger, Matthias; Salmanton-Garcia, Jon; Koehler, Philipp; Gangneux, Jean-Pierre; Arendrup, Maiken C; Bicanic, Tihana; Arikan-Akdagli, Sevtap; Cornely, Oliver A; Matsuo, Takahiro; Singh, Ben S; Wurster, Sebastian; Jiang, Ying; Bhutani, Manoop S; Kontoyiannis, Dimiitrios P; Hofmann, JustIn; Sobhanie, Mohammad Mahdee; Doctor, Medical; Sarwar, Sajed; Hebert, Courtney; Raabe, Nathan; Zhao, Yanan; Paderu, Padmaja; Shields, Ryan K; Clancy, Cornelius J; Nguyen, Minh-Hong; Ajayi, Eloho; Sikora, Anna; Klinkova, Olga; Cozzini, Lisa; Pasikhova, Yanina; Quilitz, Rod; Morrison, Austin R; Baluch, Aliyah; Hess, Danielle; Abu Saleh, Omar M; Enzler, Mark; Jannetto, Paul J; Mara, Kristin; Stevens, Ryan W; Vergidis, Paschalis; Rivera, Christina G; Gupta, Aanchal; Ranganath, Nischal; Mendoza, Maria A; Diseases, Infectious; Deml, Sharon; Wengenack, Nancy; Vergidis, Paschalis; Singh, Gagandeep; Xess, Immaculata; Chowdhury, Souradeep; Soneja, Manish; Sachdev, Janya; Iram, Azka; Chen, Yung-chun; Chang, Chao-chin; Lodise, Thomas Jr; Garey, Kevin W; Nathanson, Brian H; Buck, Margaret; Carr, Dustin R; Bremmer, Derek N; Jenniches, Daniel; Babowice, James; Chung, Eunice L; Ordaya, Eloy E; Abu Saleh, Omar M; Vergidis, Paschalis; Deml, Sharon; Wengenack, Nancy; Fida, Madiha; Agrawal, Pranjal; Yazdy, Golsa M; Ghanem, Khalil G; Handa, Victoria L; Sobel, Jack D; Zhang, Sean; Tuddenham, Susan; Prattes, Juergen; King, Thomas; Azie, Nkechi; Angulo, David A; Kung, Vanessa; Henao-Martínez, Andrés F; Tagawa, Alex; Kennis, Matthew; Franco-Paredes, Carlos; Vargas Barahona, Lilian; Shapiro, Leland; Chastain, Daniel B

P057 All- cause mortality in patients with invasive Candidiasis or candidemia from an interim analysis of a Phase 3 Open-label Study (FURI)

P057 侵袭性念珠菌病或念珠菌血症患者的全因死亡率(来自一项 3 期开放标签研究的中期分析)(FURI)

Mendoza, Leonel; Vilela, Raquel; Prattes, Juergen; King, Thomas; Azie, Nkechi; Angulo, David